Clinical Characteristics and Treatment Efficacy in Patients With SARS-CoV-2 Positivity After Nirmatrelvir-Ritonavir Therapy
The Rising Concern of Persistent SARS-CoV-2 Infection In recent studies, an alarming pattern has emerged where some patients remain SARS-CoV-2 positive even after completing a standard 5-day course of Nirmatrelvir-ritonavir (NMV-r) treatment. This phenomenon raises significant questions about the treatment’s duration and efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Could longer treatment courses … Read more